In the BioHarmony Drug Report Database

"Preview" Icon

Epinephrine

Adrenaclick, Adrenalin, Auvi-q, Bronkaid Mist, Epi E Z Pen Jr, Epinephrine, Epipen, Epipen E Z Pen, Epipen Jr, Primatene Mist, Sus-phrine Sulfite Free, Symjepi, Twinject (epinephrine) is a small molecule pharmaceutical. Epinephrine was first approved as Adrenaclick on 1982-01-01. It is used to treat airway obstruction, anaphylaxis, bradycardia, bronchial spasm, and heart arrest amongst others in the USA. The pharmaceutical is active against alpha-2A adrenergic receptor and alpha-1D adrenergic receptor. In addition, it is known to target alpha-1B adrenergic receptor, beta-2 adrenergic receptor, alpha-1A adrenergic receptor, alpha-2C adrenergic receptor, beta-1 adrenergic receptor, beta-3 adrenergic receptor, carbonic anhydrase 1, alpha-2B adrenergic receptor, and e Lysozyme murein hydrolase. Gingi-pak max 2-ply’s patents are valid until 2037-12-21 (FDA).

 

Trade Name

 

Adrenaclick, Adrenalin, Auvi-q, Bronkaid Mist, Epi E Z Pen Jr, Epinephrine, Epipen, Epipen E Z Pen, Epipen Jr, Primatene Mist, Sus-phrine Sulfite Free, Symjepi, Twinject
 

Common Name

 

epinephrine
 

ChEMBL ID

 

CHEMBL679
 

Indication

 

airway obstruction, anaphylaxis, bradycardia, bronchial spasm, heart arrest, heart block, hypotension, open-angle glaucoma, septic shock, ventricular fibrillation, ventricular tachycardia
 

Drug Class

 

Image (chem structure or protein)

Epinephrine structure rendering